Host cis-mediated extinction of a retrovirus permissive for expression in embryonal stem cells during differentiation

Journal of Virology

Volumn 72, Issue 1, 1998, Pages 339-348

  Laker, Christine ^a   Meyer, Johann ^a   Schopen, Arndt ^a   Friel, Jutta ^a   Heberlein, Christoph ^a   Ostertag, Wolfram ^a   Stocking, Carol ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ERYTHROPOIETIN; INTERLEUKIN 3; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENHANCER REGION; FETUS LIVER; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RETROVIRUS; STEM CELL; VIRUS GENOME;

EID: 0031975190     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.1.339-348.1998     Document Type: Article

References (70)

1. Akgün, E., M. Ziegler, and M. Grez. 1991. Determinants of retrovirus gene expression in embryonal carcinoma cells. J. Virol. 65:382-388.
2. Allshire, R. C., J.-P. Javerzat, N. J. Redhead, and G. Cranston. 1994. Position effect variegation at fission yeast centromeres. Cell 76:157-169.
3. Aparicio, O. M., and D. E. Gottschling. 1994. Overcoming telomeric silencing: a trans-activator competes to establish gene expression in a cell cycle-dependent way. Genes Dev. 8:1133-1146.
4. Asche, W., G. Colletta, G. Warnecke, P. Nobis, S. Pennie, R. M. King, and W. Ostertag. 1984. Lack of retrovirus gene expression in somatic cell hybrids of Friend cells and teratocarcinoma cells with a teratocarcinoma phenotype. Mol. Cell. Biol. 4:923-930.
5. Barklis, E., R. C. Mulligan, and R. Jaenisch. 1986. Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cells. Cell 47:391-399.
6. Baum, C., P. Forster, S. Hegewisch-Becker, and K. Harbers. 1994. An optimized electroporation protocol applicable to a wide range of cell lines. BioTechniques 17:1058-1062.
7. Baum, C., S. Hegewisch-Becker, H.-G. Eckert, C. Stocking, and W. Ostertag. 1995. Novel retroviral vectors for efficient gene expression of the multi-drug resistance (mdr-1) gene in early hemopoietic cells. J. Virol. 69:7541-7547.
8. Baum, C., K. Itoh, J. Meyer, C. Laker, Y. Ito, and W. Ostertag. 1997. The potent enhancer activity of the polycythemic strain of spleen focus-forming virus in hematopoietic cells is governed by a binding site for Sp1 in the upstream control region and by a unique enhancer core motif, creating an exclusive target for PEBP/Cbf. J. Virol. 71:6323-6331.
9. Berwin, B., and E. Barklis. 1993. Retrovirus-mediated insertion of expressed and non-expressed genes at identical chromosomal locations. Nucleic Acids Res. 21:2399-2407.
10. Cepko, C. L., E. F. Ryder, C. P. Austin, C. Walsh, and M. D. Fekette. 1993. Lineage analysis using retroviral vectors. Methods Enzymol. 225:933-960.
11. Challita, P.-M., and D. B. Kohn. 1994. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc. Natl. Acad. Sci. USA 92:2567-2571.
12. Challita, P.-M., D. Skelton, A. El-Khoueiry, X.-J. Yu, K. Weinberg, and D. B. Kohn. 1995. Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells. J. Virol. 69:748-755.
13. Dzierzak, E. A., T. Papayannopoulou, and R. Mulligan. 1988. Lineage-specific expression of a human β-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells. Nature 331:35-41.
14. Eckert, H.-G., M. Stockschläder, U. Just, S. Hegewisch-Becker, M. Grez, A. Uhde, A. Zander, W. Ostertag, and C. Baum. 1996. High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors. Blood 88:3407-3415.
15. Ellis, J., K. C. Tan-Un, A. Harper, D. Michalovich, N. Yannoutsos, S. Philipsen, and F. Grosveld. 1996. A dominant chromatin-opening activity in 5′ hypersensitive site 3 of the human β-globin locus control region. EMBO J. 15:562-568.
16. Felsenfeld, G. 1992. Chromatin as an essential part of the transcription mechanism. Nature 355:219-224.
17. Franz, T., F. Hilberg, B. Seliger, C. Stocking, and W. Ostertag. 1986. Retroviral mutants efficiently expressed in embryonal carcinoma cells. Proc. Natl. Acad. Sci. USA 83:3292-3296.
18. Gautsch, J. W. 1980. Embryonal carcinoma stem cells lack a function required for virus replication. Nature 285:110-112.
19. Gautsch, J. W., and M. C. Wilson. 1983. Delayed de novo methylation in teratocarcinoma suggests additional tissue-specific mechanisms for controlling gene expression. Nature 301:32-37.
20. Golemis, E. A., N. A. Speck, and N. Hopkins. 1990. Alignment of U3 region sequences of mammalian type C viruses: identification of highly conserved motifs and implications for enhancer design. J. Virol. 64:534-542.
21. Greiser-Wilke, I., W. Ostertag, P. Goldgarb, A. Lang, M. Furasawa, and J. F. Conscience. 1981. Inducibility of spleen focus forming virus by BUdR is controlled by the differentiated state of the cell. Proc. Natl. Acad. Sci. USA 78:2995-2999.
22. Grez, M., E. Akgün, F. Hilberg, and W. Ostertag. 1990. Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells Proc. Natl. Acad. Sci. USA 87:9202-9206.
23. Grez, M., M. Zörnig, J. Nowock, and M. Ziegler. 1991. A single point mutation activates the Moloney murine leukemia virus long terminal repeat in embryonal stem cells. J. Virol. 65:4691-1698.
24. Harbers, K., A. Schnieke, H. Stuhlmann, D. Jähner, and R. Jaenisch. 1981. DNA methylation and gene expression: endogenous retroviral genomes become infectious after molecular cloning. Proc. Natl. Acad. Sci. USA 78: 7609-7613.
25. Henikoff, S. 1992. Position effect and related phenomena. Curr. Opin. Genet. Dev. 2:907-912.
26. Hilberg, F., C. Stocking, W. Ostertag, and M. Grez. 1987. Functional analysis of a retroviral host-range mutant: altered long terminal repeat sequences allow expression in embryonal carcinoma cells. Proc. Natl. Acad. Sci. USA 84:5232-5236.
27. Hoeben, R. C., A. A. J. Migchielsen, R. C. M. van der Jagt, H. van Ormondt, and A. J. van der Eb. 1991. Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position. J. Virol. 65:904-912.
28. Iscove, N. N., and F. Sieber. 1975. Erythroid progenitors in mouse bone marrow detected by macroscopic colony formation in culture. Exp. Hematol. 3:32-43.
29. Jaenisch, R. 1976. Germ line integration and Mendelian transmission of the exogenous Moloney leukemia virus. Proc. Natl. Acad. Sci. USA 73:1260-1264.
30. Jaenisch, R., H. Fan, and B. Croker. 1975. Infection of preimplantation mouse embryos and of newborn mice with leukemia virus: tissue distribution of viral DNA and RNA and leukemogenesis in the adult animal. Proc. Natl. Acad. Sci. USA 72:4008-4012.
31. Jähner, D., and R. Jaenisch. 1985. Retrovirus-induced de novo methylation of flanking host sequences correlates with gene inactivity. Nature 315:594-597.
32. Jähner, D., H. Stuhlmann, C. Stewart, K. Harbers, J. Löhler, I. Simon, and R. Jaenisch. 1982. De novo methylation and expression of retroviral genomes during mouse embryogenesis. Nature 298:623-628.
33. Keller, G., and R. Snodgrass. 1990. Life span of multipotential hematopoietic stem cells in vivo. J. Exp. Med. 171:1407-1418.
34. Laker, C., C. Stocking, U. Bergholz, N. Hess, J. DeLamarter, and W. Ostertag. 1987. Autocrine stimulation after transfer of the granulocyte/macrophage colony stimulating factor gene and autonomous growth are distinct but interdependent steps in the oncogenic pathway. Proc. Natl. Acad. Sci. USA 84:8458-8462.
35. Lewin, B. 1994. Chromatin and gene expression: constant questions but changing answers. Cell 79:397-406.
36. Lob, T. P., L. L. Sievert, and R. W. Scott. 1990. Evidence for a stem cell-specific repressor of Moloney murine leukemia virus expression in embryonal carcinoma cells. Mol. Cell. Biol. 10:4045-4057.
37. Lohse, P., and H. H. Arnold. 1988. The down-regulation of the chicken cytoplasmic β actin during myogenic differentiation does not require the gene promoter but involves the 3′ end of the gene. Nucleic Acids Res. 16:2787-2803.
38. Lohuizen, M. v., S. Verbeek, B. Scheijen, E. Wientjens, H. van der Gulden, and A. Berns. 1991. Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging. Cell 65:737-752.
39. Markowitz, D., S. Goff, and A. Bank. 1988. Construction and use of a safe and efficient amphotropic packaging cell line. Virology 164:400-406.
40. Nagy, A., E. Gocza, E. Mentez-Diaz, R. Prideaux, E. Ivanyi, M. Markkula, and J. Rosant. 1990. Embryonic stem cells alone are able to support fetal development in the mouse. Development 110:815-821.
41. Nagy, A., and J. Rossant. 1993. Production of completely ES cell-derived fetuses, p. 147-179. In A. L. Joyner (ed.), Gene targeting. IRL Press, Oxford, United Kingdom.
42. Nagy, A., J. Rossant, R. Nagy, W. Abranow-Newerly, and J. C. Roder. 1993. Derivation of completely cell culture-derived mice from early-passage embrvonic stem cells. Proc. Natl. Acad. Sci. USA 90:8424-8428.
43. Niwa, O., Y. Yokota, H. Ishida, and T. Sugahara. 1983. Independent mechanisms involved in the suppression of Moloney murine leukemia virus genome during differentiation of murine teratocarcinoma cells. Cell 32:1105-1113.
44. Palmer, T. D., G. J. Rosman, W. R. Osborne, and A. D. Miller. 1991. Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc. Natl. Acad. Sci. USA 88:1330-1334.
45. Paranjape, S. M., R. T. Kamakaka, and J. T. Kodonaga. 1994. Role of chromatin structure in the regulation of gene expression. Annu. Rev. Biochem. 63:265-297.
46. Paro, R. 1995. Propagating memory of transcriptional states. Trends Genet. 118:295-297.
47. Petersen, R., G. Kempler, and E. Barklis. 1991. A stem cell-specific silencer in the primer-binding site of a retrovirus. Mol. Cell. Biol. 11: 1214-1221.
48. Phi-Van, L., J. P. von Kries, W. Ostertag, and W. H. Strätling. 1990. The chicken lysozyme 5′ matrix attachment region increases transcription from a heterologous promoter in heterologous cells and dampens position effects on the expression of transfected genes. Mol. Cell. Biol. 10: 2302-2307.
49. Prince, V. E., and P. W. J. Rigby. 1991. Derivatives of Moloney murine sarcoma virus capable of being transcribed in embryonal carcinoma stem cells have gained a functional Sp1 binding site. J. Virol. 65:1803-1811.
50. Quischke, W. W., Z.-Y. Lin, L. DePonti-Zilli, and B. M. Paterson. 1989. The β actin promoter: high levels of transcription depend upon a CCAAT binding factor. J. Biol. Chem. 264:9539-9546.
51. Robertson, E., A. Bradley, M. Kuehn, and M. Evans. 1986. Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vectors. Nature 323:445-448.
52. Robertson, G., D. Garrick, W. Wu, M. Kearns, and D. Martin. 1995. Position-dependent variegation of globin transgene expression in mice. Proc. Natl. Acad. Sci. USA 92:5371-5375.
53. Savatier, P., J. Morgenstern, and R. S. P. Beddington. 1990. Permissiveness to murine leukemia virus expression during implantation and early postimplantation mouse development. Development 109:655-665.
54. Scharfmann, R., J. H. Axelrod, and I. M. Verma. 1991. Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc. Natl. Acad. Sci. USA 88:4626-4630.
55. Schnieke, A., K. Harbers, and R. Jaenisch. 1983. Embryonic lethal mutation in mice induced by retroviral insertion into the α-1(I) collagen gene. Nature 304:315-320.
56. Seliger, B., R. Kollek, C. Stocking, T. Franz, and W. Ostertag. 1986. Viral transfer, transcription, and rescue of a selectable myeloproliferative sarcoma virus in embryonal cell lines: expression of the mos oncogene. Mol. Cell. Biol. 6:286-293.
57. Sheridan, P. L., C. T. Sheline, K. Cannon, M. L. Voz, M. J. Pazin, J. T. Kodonaga, and K. A. Jones. 1995. Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro. Genes Dev. 9:2090-2104.
58. Shimotono, K., and H. Temin. 1981. Formation of infectious progeny after insertion of herpes Tk gene into DNA of an avian retrovirus. Cell 46:19-29.
59. Soriano, P., R. D. Cone, R. C. Mulligan, and R. Jaenisch. 1986. Tissue-specific and ectopic expression of genes introduced into transgenic mice by retroviruses. Science 234:1409-1413.
60. Soriano, P., and R. Jaenisch. 1986. Retroviruses as probes for mammalian development: allocation of cells to the somatic and germ cell lineages. Cell 46:18-29.
61. Speck, N. A., and D. Baltimore. 1987. Six distinct nuclear (actors interact with the 75-base-pair repeats of the Moloney murine leukemia virus enhancer. Mol. Cell. Biol. 7:435-439.
62. Stewart, C. L., S. Schuetze, M. Vanek, and E. F. Wagner. 1987. Expression of retroviral vectors in transgenic mice obtained by embryo infection. EMBO J. 6:383-388.
63. Stewart, C. L., H. Stuhlmann, D. Jahner, and R. Jaenisch. 1982. De novo methylation, expression, and infectivity of retroviral genomes introduced into embryonal carcinoma cells. Proc. Natl. Acad. Sci. USA 79:4098-4102.
64. Stocking, C., U. Bergholz, J. Friel, K. Klingler, T. Wagener, C. Starke, T. Kitamura, A. Miyajima, and W. Ostertag. 1993. Distinct classes of factor-independent mutants can be isolated after retroviral mutagenesis of a human myeloid stem cell line. Growth Factors 8:197-209.
65. Stocking, C., M. Grez, and W. Ostertag. 1993. Regulation of retrovirus infection and expression in embryonic and hematopoietic stem cells, p. 433-455. In W. Doerfler and P. Boehm (ed.), Virus strategies. VCH Verlag, Heidelberg, Germany.
66. Stocking, C., R. Kollek, U. Bergholz, and W. Ostertag. 1985. Long terminal repeat sequences impart hemopoietic transformation properties to the myeloproliferative sarcoma virus. Proc. Natl. Acad. Sci. USA 82:4098-4102.
67. Tsukiyama, T., O. Niwa, and K. Yokoro. 1991. Analysis of the binding proteins and activity of the long terminal repeat of Moloney murine leukemia virus during differentiation of mouse embryonal carcinoma cells. J. Virol. 65:2979-2986.
68. Tsukiyama, T., H. Ueda, S. Hirose, and O. Niwa. 1992. Embryonal long terminal repeat-binding protein is a murine homolog of FTZ-F1, a member of the steroid receptor superfamily. Mol. Cell. Biol. 12:1286-1291.
69. Walters, M. C., W. Magis, S. Fiering, J. Eidemiller, D. Scalzo, M. Groudine, and D. I. K. Martin. 1996. Transcriptional enhancers act in cis to suppre position-effect variegation. Genes Dev. 10:185-195.
70. Weiher, H., E. Barklis, W. Ostertag, and R. Jaenisch. 1987. Two distinct sequence elements mediate retroviral gene expression in embryonal carcinoma cells. J. Virol. 61:2742-2746.